Jiying Technology

Jiying Technology, based in Hong Kong Science Park, Hong Kong, develops AI-powered medical technologies at the intersection of clinical medicine, artificial intelligence, pharmacy, and genetics, focusing on early digestive system cancer detection, recognition, and genomic information prediction using deep learning. Their products aim to improve doctors' diagnosis efficiency and support cancer treatment through advanced AI and genetic technology. The company's R&D personnel are highly credentialed, with 100% holding Master's degrees or higher, and 85% possessing Doctorates, contributing to its 3 invention patents and 1 utility model patent applications. Founder and CEO Qiu Hesong, recognized as an Outstanding Young Entrepreneur in the Guangdong-Hong Kong-Macao Greater Bay Area, leads the organization. Jiying Technology was established in May 2019 by Qiu Hesong and a team of experts.